Results 121 to 130 of about 27,201 (202)

Leveraging neural network models for drug repurposing: a case study on cardiac hypertrophy. [PDF]

Sci Rep
Magnusson R, Johansson M, Hagvall S, Synnergren J.   +3 more
europepmc   +1 more source

Lapatinib induces ferroptosis in osteosarcoma via the SLC1A5-GPX4 axis. [PDF]

J Bone Oncol
Miao H, Fu X, Liu B, Pan X, Han Y, Yu Z.
europepmc   +1 more source

Rapamycin Partially Reverts Cavernoma Endothelial Cell Phenotype and, When Combined With Lapatinib, Ameliorates Chronic Lesions. [PDF]

J Cell Mol Med
García-Colomer M, Martínez JE, Díaz-Gómez L, Sartages M, Esquinas-Román EM, Riobello C, Martínez-Delgado D, González-Pérez D, Gómez-Durán A, Fidalgo M, Varela-Rey M, Pombo CM, Zalvide J.   +12 more
europepmc   +1 more source

Real-world treatment patterns and associated outcomes in patients with HER2-positive unresectable or metastatic breast cancer: the HER2 REAL Study. [PDF]

ESMO Open
Lee SC, Barrios C, Chung WP, Kai Cheong RN, Im SA, Hui R, Tung T.   +6 more
europepmc   +1 more source

Disitamab vedotin for HER2-positive breast cancer with liver metastases: phase 3 results from the RC48-C006 phase 2/3 trial. [PDF]

Nat Commun
Wang J, Ouyang Q, Xie W, Niu Z, Zhang Q, Yan X, Teng Y, Chang J, Cheng Y, Wang A, Wang J, Yao H, Yang Z, Sun T, Tong Z, Wu X, Wang Y, Zhou E, Kong X, Wang X, Zeng, Gu S, Hou Y, Gao D, Qu Z, Han C, Fang J, Xu B.   +27 more
europepmc   +1 more source

Efficacy and Safety Ranking of HER2-Targeted TKIs in Advanced Breast Cancer: A Bayesian Network Meta-Analysis. [PDF]

Clin Med Insights Oncol
Li R, Huangfu R, Lan H, Zhang C, Hou K, Ping Y.   +5 more
europepmc   +1 more source

Cost-effectiveness analysis of the treatment pathway after trastuzumab treatment failure in patients with HER2-positive advanced breast cancer: a chinese health system perspective. [PDF]

BMC Health Serv Res
Zhou T, Zhang Y, Li C, Wu N, Liu Z, Wei J, Cai N, Xu S.   +7 more
europepmc   +1 more source

Use of the dual tyrosine kinase inhibitor lapatinib for the treatment of vulvovaginal squamous cell carcinoma in a dog. [PDF]

J Vet Intern Med
Vardanega MJ, Longo T, Aceino A, Alexander CK.   +3 more
europepmc   +1 more source

Advances in the design and discovery of small-molecule tyrosine kinase inhibitors for breast cancer. [PDF]

RSC Adv
Elwaie TA, Aref MMA, Ali HI.
europepmc   +1 more source

Recent advances in HER2-targeted inhibitors for cancer therapy. [PDF]

Pharm Sci Adv
Zhu W, Lu X.
europepmc   +1 more source